Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia

被引:3
|
作者
Vanhooren, Jolien [1 ,2 ,3 ]
Van Camp, Laurens [1 ,2 ,3 ]
Depreter, Barbara [4 ]
de Jong, Martijn [1 ,2 ,3 ]
Uyttebroeck, Anne [5 ]
Van Damme, An [6 ]
Dedeken, Laurence [7 ]
Dresse, Marie-Francoise [8 ]
ten Bosch, Jutte van der Werff [9 ]
Hofmans, Mattias [3 ,10 ]
Philippe, Jan [3 ,10 ]
De Moerloose, Barbara [1 ,2 ,3 ]
Lammens, Tim [1 ,2 ,3 ]
机构
[1] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, B-9000 Ghent, Belgium
[2] Univ Ghent, Dept Internal Med & Pediat, B-9000 Ghent, Belgium
[3] Canc Res Inst Ghent CRIG, B-9000 Ghent, Belgium
[4] Vrije Univ Brussel VUB, Universitair Ziekenhuis Brussel, Dept Lab Hematol, B-1050 Brussels, Belgium
[5] Univ Hosp Gasthuisberg, Dept Pediat, B-3000 Leuven, Belgium
[6] Univ Hosp St Luc, Dept Pediat Hematol Oncol, B-1200 Brussels, Belgium
[7] Queen Fabiola Childrens Univ Hosp, Dept Pediat Hematol Oncol, B-1020 Brussels, Belgium
[8] Univ Hosp Liege, Dept Pediat Hematol Oncol, B-4000 Liege, Belgium
[9] Univ Hosp Brussel, Dept Pediat Hematol Oncol, B-1090 Brussels, Belgium
[10] Univ Ghent, Dept Diagnost Sci, B-9000 Ghent, Belgium
关键词
pediatric AML; non-coding RNA; cellular subpopulations; STEM-CELLS; PROGRESSION; EXPRESSION; CANCER; PROLIFERATION; SUPPRESSES; APOPTOSIS; GENE;
D O I
10.3390/cancers14092098
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Survival rates for children with acute myeloid leukemia have significantly improved in recent decades. Still, 20-30% will succumb to therapy-related toxicity and relapse. Research has shown that leukemic stem cells (LSCs) in particular are responsible for relapse. Therefore, the characterization of the LSC is needed to improve the current treatment options for and survival of these pediatric patients. Previously, research has focused mainly on the protein-coding part of the human genome, but recently the focus has also shifted to non-coding genes, including long non-coding RNA (lncRNA) and microRNA (miRNA). The aim of this study was to investigate the expression of lncRNAs and miRNAs in pediatric AML subpopulations (LSCs and leukemic blasts) and their normal counterparts (hematopoietic stem cells and control myeloblasts). We provide here a unique set of non-coding RNAs with a potential role in the pathogenesis of pediatric AML, paving the way for further translational research studies. Pediatric acute myeloid leukemia (pedAML) is a heterogeneous blood cancer that affects children. Although survival rates have significantly improved over the past few decades, 20-30% of children will succumb due to treatment-related toxicity or relapse. The molecular characterization of the leukemic stem cell, shown to be responsible for relapse, is needed to improve treatment options and survival. Recently, it has become clear that non-coding RNAs, including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), play a role in the development of human diseases, including pediatric cancer. Nevertheless, non-coding RNA expression data in pedAML are scarce. Here, we explored lncRNA (n = 30,168) and miRNA (n = 627) expression in pedAML subpopulations (leukemic stem cells (LSCs) and leukemic blasts (L-blasts)) and their normal counterparts (hematopoietic stem cells and control myeloblasts). The potential regulatory activity of differentially expressed lncRNAs in LSCs (unique or shared with the L-blast comparison) on miRNAs was assessed. Moreover, pre-ranked gene set enrichment analyses of (anti-) correlated protein-coding genes were performed to predict the functional relevance of the differentially upregulated lncRNAs in LSCs (unique or shared with the L-blast comparison). In conclusion, this study provides a catalog of non-coding RNAs with a potential role in the pathogenesis of pedAML, paving the way for further translational research studies.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia
    Yin, Xuejiao
    Huang, Sui
    Zhu, Ruiqi
    Fan, Fengjuan
    Sun, Chunyan
    Hu, Yu
    CANCER CELL INTERNATIONAL, 2018, 18
  • [22] Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia
    Xuejiao Yin
    Sui Huang
    Ruiqi Zhu
    Fengjuan Fan
    Chunyan Sun
    Yu Hu
    Cancer Cell International, 18
  • [23] A Prognostic Autophagy-Related Long Non-coding RNA (ARlncRNA) Signature in Acute Myeloid Leukemia (AML)
    Zhao, Chunxia
    Wang, Yulu
    Tu, Famei
    Zhao, Shuai
    Ye, Xiaoying
    Liu, Jing
    Zhang, Juan
    Wang, Zifeng
    FRONTIERS IN GENETICS, 2021, 12
  • [24] Long non-coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia
    Tan, Zhenqing
    Zhu, Kaibo
    Yin, Yafei
    Luo, Zimian
    MOLECULAR MEDICINE REPORTS, 2021, 23 (02)
  • [25] ELUCIDATING THE ROLE OF THE LONG NON-CODING RNA DANCR IN LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA (AML)
    Bill, Marius
    Karunasiri, Malith
    Burke, Matthew
    Walker, Allison
    Volinia, Stefano
    Bloomfield, Clara
    Garzon, Ramiro
    Dorrance, Adrienne
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : S124 - S124
  • [26] Clinical relevance of long non-coding RNA in acute myeloid leukemia: A systematic review with meta-analysis
    Priya
    Garg, Manoj
    Talwar, Rashmi
    Bharadwaj, Mohit
    Ruwali, Munindra
    Pandey, Amit Kumar
    LEUKEMIA RESEARCH, 2024, 147
  • [27] Hoxblinc Is Aberrantly Expressed in Acute Myeloid Leukemia and Functions As a Potent Oncogenic Long Non-Coding RNA in Leukemogenesis
    Zhu, Ganqian
    Luo, Huacheng
    Chen, Shi
    Lai, Qian
    Guo, Ying
    Guryanova, Olga A.
    Qiu, Yi
    Yang, Feng-Chun
    Li, Wei
    Nimer, Stephen D.
    Huang, Suming
    Xu, Mingjiang
    BLOOD, 2018, 132
  • [28] Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk
    Wang, Yong
    CANCER BIOMARKERS, 2019, 26 (01) : 93 - 108
  • [29] Targeting the non-coding and stem cell signature in childhood acute myeloid leukemia
    Schueler, L.
    Winkler, R.
    Christmann, M.
    Schuschel, K.
    Goncalves, Dias J.
    Cetin, R.
    Kaulich, M.
    Heckl, D.
    Bhayadia, R.
    Klusmann, J. H.
    KLINISCHE PADIATRIE, 2024, 236 (03): : 213 - 214
  • [30] Non-coding RNA annotation:Deciphering the second genetic code
    QU LiangHu
    Science China(Life Sciences), 2013, 56 (10) : 865 - 866